CN112345744A - Assembly line system and test method thereof - Google Patents

Assembly line system and test method thereof Download PDF

Info

Publication number
CN112345744A
CN112345744A CN201910722319.8A CN201910722319A CN112345744A CN 112345744 A CN112345744 A CN 112345744A CN 201910722319 A CN201910722319 A CN 201910722319A CN 112345744 A CN112345744 A CN 112345744A
Authority
CN
China
Prior art keywords
sample
module
quality control
state
analysis module
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910722319.8A
Other languages
Chinese (zh)
Other versions
CN112345744B (en
Inventor
王鑫润
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Mindray Bio Medical Electronics Co Ltd
Original Assignee
Shenzhen Mindray Bio Medical Electronics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Mindray Bio Medical Electronics Co Ltd filed Critical Shenzhen Mindray Bio Medical Electronics Co Ltd
Priority to CN201910722319.8A priority Critical patent/CN112345744B/en
Publication of CN112345744A publication Critical patent/CN112345744A/en
Application granted granted Critical
Publication of CN112345744B publication Critical patent/CN112345744B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4905—Determining clotting time of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1009—Characterised by arrangements for controlling the aspiration or dispense of liquids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)

Abstract

A pipeline system and test method of the pipeline system, can keep analyzing the module all online in the whole course of quality control and test, after putting into quality control sample and patient's sample, no longer need users to participate in and operate too much; in addition, in the whole test process, quality control test and pretreatment of the patient sample are performed in parallel, and when any one of the analyzers is controlled, project test of the patient sample can be started, so that any one of the analyzers in control does not need to wait for other analyzers, the time that the in-control instrument can test the patient sample is fully utilized, and the test efficiency is improved.

Description

Assembly line system and test method thereof
Technical Field
The invention relates to a pipeline system and a test method of the pipeline system.
Background
With the need for large numbers of assay samples, in order to meet high throughput and reduce time, pipeline systems have emerged that pipeline samples. A very large link for traditional sample determination is sample pretreatment, the time spent in the link can be greatly shortened after a production line is introduced, the production line receives a sample put by a user firstly, then the sample is subjected to pretreatment in a centralized mode, such as automatic code scanning, sample sorting, centrifugation, cover removing and the like, the pretreated sample is distributed to a corresponding analyzer according to the test items of the sample, after the sample is determined by the analyzer, some production lines can perform aftertreatment on the sample, such as film re-coating or cover adding on the sample, and then the sample is dispatched to a refrigeration storage module on the production line to be stored so as to back up the sample, so that when the determination result has problems or disagrees, the sample can be dispatched from the refrigeration storage module on the production line again to be retested.
Whether they are pipelined systems or conventional stand-alone test instruments, they require quality control testing of the patient's test items prior to performing the patient sample test in order to view the status of the corresponding items of the instrument. For a pipeline system, since a plurality of analysis instruments are cascaded, a quality control test needs to be performed on each analysis instrument, and for any one analysis instrument, if a result of the quality control test is abnormal, that is, out of control, the current state of the instrument cannot guarantee the accuracy of a test result obtained after an out of control item is performed on a patient sample, at this time, the out of control item of the instrument needs to be subjected to out of control processing, for example, the out of control item is tested again to confirm whether out of control is performed, for example, the quality control item is replaced, for example, a reagent is replaced, and the patient sample cannot be tested until the out of control item is controlled again, because the instrument cannot guarantee the accuracy of the item test result of the patient sample.
In order to ensure the accuracy of the test result, a current common test strategy is a serial strategy of quality control test and patient sample test, i.e. quality control test is performed on each analysis instrument of the assembly line system, and after the analysis instruments are controlled, the analysis instruments are started to perform item test on the patient sample. There are two specific ways to implement the serial strategy of quality control testing and patient sample testing, which are described in detail below.
In the first mode, all the analytical instruments on the assembly line are on line, a user inputs quality control samples in an input area of the assembly line, the assembly line system distributes the quality control samples to the corresponding analytical instruments, and the analytical instruments start to perform quality control tests; when the analysis instruments are controlled, the user puts the patient samples into the general input area of the production line, and the production line system pre-processes the patient samples from the general input area and then redistributes the patient samples to the corresponding analysis instruments to perform the project tests of the patient samples.
The second mode is that a user firstly manually takes off all the analysis instruments on the assembly line, then puts a quality control sample into a sample loading area of each analysis instrument and starts a test, on the other hand, the user also puts a patient sample into an input area of the assembly line and starts the pretreatment of the patient sample, and after the patient sample is processed, the patient sample is dispatched to a preset area to wait; in the process, a user checks the quality control test result of each analysis instrument in real time, and after the user checks that the analysis instruments are controlled, the analysis instruments are switched to be on-line to start the test, and then the pipeline system dispatches the waiting patient sample and the subsequent patient sample to the corresponding analysis instruments for testing.
Both of the above two approaches to quality control of pipeline systems have significant drawbacks.
Disclosure of Invention
In order to solve the above problems, the present application provides a pipeline system and a method for testing the pipeline system.
According to a first aspect, there is provided in an embodiment a pipeline system comprising:
the input module is used for receiving the sample in an input area and identifying the type of the sample; wherein the samples comprise quality control samples for quality control and patient samples to be tested;
the pretreatment module is used for pretreating a sample; the pretreatment module comprises one or more of a centrifugation module, a serum detection module, a decapping module and a dispensing module; the centrifugal module is used for centrifuging a sample to be centrifuged; the serum detection module is used for detecting whether the serum amount of the sample is enough and/or whether the serum quality of the sample is qualified; the decapping module is used for decapping the centrifuged sample; the separate injection module is used for separating samples;
one or more analysis modules for testing the sample;
the post-processing module is used for performing post-processing on the sample;
the system comprises a track, a scheduling device and a controller, wherein the track is connected with each module; wherein:
when the input module identifies that the sample type is a quality control sample, the scheduling device schedules the quality control sample to a corresponding analysis module for quality control test, when the controller judges that the test result of each quality control item in the quality control item set of the analysis module is controlled, the state of the analysis module is marked as an on-control state, and when the controller judges that the quality control item in the quality control item set of the analysis module is out of control or the result of the quality control item is not present, the state of the analysis module is marked as a shielding state;
when the input module identifies that the sample type is a patient sample, the preprocessing module preprocesses the patient sample, the controller determines the state of an analysis module which needs to test the patient sample for the preprocessed patient sample, if the state is in a control state, the scheduling device schedules the patient sample to the analysis module for testing, and if the state is in a shielding state, the controller controls the scheduling device not to schedule the patient sample to the analysis module for testing.
According to a second aspect, there is provided in an embodiment a pipeline system comprising:
an input module for receiving a patient sample to be tested at an input area thereof;
the pretreatment module is used for pretreating a sample; the pretreatment module comprises one or more of a centrifugation module, a serum detection module, a decapping module and a dispensing module; the centrifugal module is used for centrifuging a sample to be centrifuged; the serum detection module is used for detecting whether the serum amount of the sample is enough and/or whether the serum quality of the sample is qualified; the decapping module is used for decapping the centrifuged sample; the separate injection module is used for separating samples;
one or more analysis modules for testing the sample;
the post-processing module is used for performing post-processing on the sample;
the system comprises a track, a scheduling device and a controller, wherein the track is connected with each module; wherein:
the scheduling device schedules the patient sample to a pretreatment module from an input module, and the pretreatment module pretreats the scheduled patient sample; the analysis module receives a quality control sample in an upper sample area of the analysis module and performs quality control test, the controller marks the state of the analysis module as an on-control state when judging that the test result of each quality control item in the quality control item set of the analysis module is in control, and marks the state of the analysis module as a shielding state when judging that the quality control item in the quality control item set of the analysis module is out of control or the result of the quality control item does not exist;
for a pre-processed patient sample, the controller determines the state of an analysis module which needs to test the patient sample, if the state is in a control state, the scheduling device schedules the patient sample to the analysis module for testing, and if the state is in a shielding state, the controller controls the scheduling device not to schedule the patient sample to the analysis module for testing.
According to a third aspect, an embodiment provides a pipeline system comprising:
the input module is used for receiving the sample in an input area and identifying the type of the sample; wherein the samples comprise quality control samples for quality control and patient samples to be tested;
the pretreatment module is used for pretreating a sample; the pretreatment module comprises one or more of a centrifugation module, a serum detection module, a decapping module and a dispensing module; the centrifugal module is used for centrifuging a sample to be centrifuged; the serum detection module is used for detecting whether the serum amount of the sample is enough and/or whether the serum quality of the sample is qualified; the decapping module is used for decapping the centrifuged sample; the separate injection module is used for separating samples;
one or more analysis modules for testing the sample;
the system comprises a track, a scheduling device and a controller, wherein the track is connected with each module; wherein:
when the input module identifies that the sample type is a quality control sample, the scheduling device schedules the quality control sample to a corresponding analysis module for quality control test, and the controller judges the state of the analysis module according to the test result of the quality control item and calibrates the state;
when the input module identifies that the sample type is a patient sample, the preprocessing module preprocesses the patient sample, for the preprocessed patient sample, the controller determines the state of an analysis module which needs to test the patient sample, and controls the scheduling device to schedule the patient sample according to the state of the analysis module.
According to a fourth aspect, there is provided in one embodiment a pipeline system comprising:
an input module for receiving a patient sample to be tested at an input area thereof;
the pretreatment module is used for pretreating a sample; the pretreatment module comprises one or more of a centrifugation module, a serum detection module, a decapping module and a dispensing module; the centrifugal module is used for centrifuging a sample to be centrifuged; the serum detection module is used for detecting whether the serum amount of the sample is enough and/or whether the serum quality of the sample is qualified; the decapping module is used for decapping the centrifuged sample; the separate injection module is used for separating samples;
one or more analysis modules for testing the sample;
the system comprises a track, a scheduling device and a controller, wherein the track is connected with each module; wherein:
the scheduling device schedules the patient sample to a pretreatment module from an input module, and the pretreatment module pretreats the scheduled patient sample;
the analysis module receives a quality control sample in an upper sample area of the analysis module, performs quality control test, and the controller judges the state of the analysis module according to the test result of a quality control project and calibrates the state of the analysis module;
for the processed patient sample, the controller determines the state of an analysis module which needs to test the patient sample, and controls the scheduling device to schedule the patient sample according to the state of the analysis module.
In one embodiment, the determining and calibrating the state of the analysis module by the controller according to the test result of the quality control item includes:
when the test results of all the quality control items in the quality control item set of the analysis module are judged to be in control, the controller marks the state of the analysis module as an in-control state; and/or the presence of a gas in the gas,
and when the test result of the quality control item in the quality control item set of the analysis module is judged to be out of control or the result of the quality control item is not obtained, the controller marks the state of the analysis module as a shielding state.
In one embodiment, the controller determines the state of the analysis module according to the test result of the quality control item and performs calibration, and further includes:
if the quality control item set of the analysis module further comprises preset non-parallel quality control items, when the test results of all the non-parallel quality control items in the quality control item set of the analysis module are judged to be in control and the test results of the rest quality control items are not in control or part of the test results of the rest quality control items are not in control, the controller also marks the state of the analysis module as in control state.
In one embodiment, when the controller determines that the analysis module is in a state where the test result of the quality control item is not in control or the test result of the quality control item is not yet in control, and the test result of the quality control item is in control, the controller releases the shielding of the analysis module, and the state of the analysis module is changed from the shielding state to the control state.
In one embodiment, for a pre-processed patient sample, when the controller determines that the state of an analysis module requiring the patient sample to be tested is in control, the controller controls the scheduling device to schedule the patient sample to the analysis module for the patient sample test; and/or when the controller determines that the state of the analysis module is the shielding state, the controller controls the scheduling device not to schedule the patient sample to the analysis module for patient sample test and controls the patient sample to wait.
In one embodiment, for a pre-processed patient sample, if the patient sample needs to be tested on a plurality of analysis modules respectively, when the controller determines that any one of the analysis modules is in a control state, the patient sample is dispatched to the analysis module in the control state for testing.
In one embodiment, for a pre-processed patient sample, if the patient sample needs to be tested on any one of a plurality of identical analysis modules, when the controller determines that any one of the analysis modules is in a control state, the patient sample is dispatched to the analysis module in the control state for testing.
In one embodiment, when the controller determines that a plurality of analysis modules are in the control state, the patient sample is dispatched to one of the analysis modules in the control state for testing according to a load balancing principle.
In one embodiment, the controller controls the waiting of the patient sample, comprising: the controller controls the scheduling device to schedule the patient sample to a preset buffer area for waiting.
In one embodiment, when the controller determines that the analysis module requiring the test on the patient sample is changed from the mask state to the on-control state for the patient sample waiting in the buffer, the controller controls the scheduling device to schedule the patient sample from the buffer to the analysis module for the test.
In one embodiment, in response to a user-input command for a set of quality control items for any one of the analysis modules, the controller sets a set of quality control items for the corresponding analysis module.
According to a fifth aspect, an embodiment provides a method for testing a pipeline system, including:
receiving samples at an input area, wherein the samples comprise quality control samples for quality control and patient samples to be tested;
identifying a sample type;
when the type of the sample is identified as a quality control sample, the quality control sample is dispatched to a corresponding analysis module for quality control test, when the test result of each quality control item in the quality control item set of the analysis module is judged to be controlled, the state of the analysis module is marked as a controlled state, and when the quality control item in the quality control item set of the analysis module is judged to be out of control or the result of the quality control item is judged not to be output, the state of the analysis module is marked as a shielding state;
when the type of the sample is identified to be the patient sample, preprocessing the patient sample, and determining the state of an analysis module which needs to test the patient sample for the preprocessed patient sample;
if the patient sample is in the control state, the patient sample is dispatched to the analysis module for testing; and/or if the patient sample is in the shielding state, the patient sample is not dispatched to the analysis module for patient sample test.
According to a sixth aspect, an embodiment provides a method for testing a pipeline system, including:
receiving a patient sample to be tested at an input area;
pre-treating a patient sample;
receiving a quality control sample in a sample loading area of an analysis module, performing quality control test, when the test result of each quality control item in a quality control item set of the analysis module is judged to be controlled, calibrating the state of the analysis module to be in a control state, and when the quality control item in the quality control item set of the analysis module is judged to be out of control or the result of the quality control item is not output, calibrating the state of the analysis module to be in a shielding state;
for the patient sample which is processed before, determining the state of an analysis module which needs to test the patient sample;
if the patient sample is under control, the patient sample is dispatched to the analysis module for testing; and/or if the patient sample is in the shielding state, the patient sample is not dispatched to the analysis module for patient sample testing.
According to a seventh aspect, an embodiment provides a computer readable storage medium comprising a program executable by a processor to implement a method as in any of the embodiments herein.
According to the pipeline system, the testing method of the pipeline system and the computer readable storage medium of the embodiment, the analysis module can be kept on line in the whole process of quality control and testing, and after a quality control sample and a patient sample are put in, excessive participation and operation of a user are not needed; in addition, in the whole test process, quality control test and pretreatment of the patient sample are performed in parallel, and when any one of the analyzers is controlled, project test of the patient sample can be started, so that any one of the analyzers in control does not need to wait for other analyzers, the time that the in-control instrument can test the patient sample is fully utilized, and the test efficiency is improved.
Drawings
FIG. 1 is a block diagram of a pipeline system according to an embodiment;
FIG. 2 is a schematic diagram of a preprocessing module according to an embodiment;
FIG. 3 is a schematic diagram of an exemplary aftertreatment module;
FIG. 4 is a block diagram of another embodiment of a pipeline system;
FIG. 5 is a method of testing a pipeline system of an embodiment;
FIG. 6 is a method for testing a pipeline system according to another embodiment.
Detailed Description
The present invention will be described in further detail with reference to the following detailed description and accompanying drawings. Wherein like elements in different embodiments are numbered with like associated elements. In the following description, numerous details are set forth in order to provide a better understanding of the present application. However, those skilled in the art will readily recognize that some of the features may be omitted or replaced with other elements, materials, methods in different instances. In some instances, certain operations related to the present application have not been shown or described in detail in order to avoid obscuring the core of the present application from excessive description, and it is not necessary for those skilled in the art to describe these operations in detail, so that they may be fully understood from the description in the specification and the general knowledge in the art.
Furthermore, the features, operations, or characteristics described in the specification may be combined in any suitable manner to form various embodiments. Also, the various steps or actions in the method descriptions may be transposed or transposed in order, as will be apparent to one of ordinary skill in the art. Thus, the various sequences in the specification and drawings are for the purpose of describing certain embodiments only and are not intended to imply a required sequence unless otherwise indicated where such sequence must be followed.
The numbering of the components as such, e.g., "first", "second", etc., is used herein only to distinguish the objects as described, and does not have any sequential or technical meaning. The term "connected" and "coupled" when used in this application, unless otherwise indicated, includes both direct and indirect connections (couplings).
Two ways to implement the quality control testing and patient sample testing serial strategies are as described above: for the first mode, the user is first required to put the quality control sample and the patient sample into the general input area of the production line in batch, and if the patient sample is put into the input area before the quality control sample, it is highly likely that the patient sample is tested under the condition that the analysis instrument is not controlled; secondly, the patient sample test can be carried out only after the analysis instruments are controlled, so that the time consumed by the quality control of the assembly line system in the previous period is too long, and the test efficiency is low; for the second mode, firstly, the user needs to manually switch the analysis instrument between the off-line mode and the on-line mode, secondly, in the process of performing the quality control test on the analysis instrument off-line mode, the user needs to pay attention to the quality control item test result of the instrument in real time, which not only brings extra workload to the user, so that the user does not have time to process other matters, but also can lead the on-control instruments to be in a test idle state if the user does not timely switch the on-control instruments to be on-line, so that the time of the instruments capable of performing the patient sample test is not fully utilized, and the test efficiency is reduced.
In one concept of the invention, a quality control sample and a patient sample can be simultaneously placed in an input area of the production line, the quality control sample and the patient sample are identified, the quality control sample is dispatched to a corresponding analysis instrument for quality control test, and the patient sample is dispatched to a pretreatment module for pretreatment; in the quality control test process, the quality control state of each analysis instrument is judged, when the analysis instrument is judged to be in control, the corresponding patient sample is dispatched to the analysis instrument to carry out the project test of the patient sample, the project test of the patient sample does not need to be started until all the analysis instruments are in control, and in other deformation concepts, the quality control sample can be respectively placed in the sample loading area of each analysis instrument to carry out the quality control test under the condition of keeping the analysis instruments on line. According to the invention, after the user puts in the quality control sample and the patient sample, the user does not need to participate and operate too much, and the situation that the user does not switch the on-control instruments to be on-line in time in the second mode does not exist; in the whole test process, the quality control test and the pretreatment of the patient sample are performed in parallel, and when any one of the analyzers is controlled, the project test of the patient sample can be started, so that any one of the analyzers in control does not need to wait for other analyzers, the time that the in-control instrument can test the patient sample is fully utilized, and the test efficiency is improved; the present invention will be specifically explained below.
Referring to fig. 1, an embodiment of a pipeline system includes an input module 10, a preprocessing module 20, one or more analysis modules 30, a post-processing module 40, a track 50, a scheduling device 60, a controller 70, and a display module 80. The track 50 is used to connect the modules, for example, the input module 10, the pre-processing module 20, the one or more analysis modules 30, the post-processing module 40, and the like, and the dispatching device 60 dispatches the samples to the corresponding modules through the track. It should be noted that the post-processing module 40 and the display module 80 are not necessary in some pipeline systems and are optional modules.
The input module 10 is used for receiving samples put by users. The input module 10 in the pipeline system is generally the area where the user puts the sample, and when the pipeline system is in operation, the input module 10 can automatically scan the sample put therein, sort the sample, and the like, so as to be processed by the next module, such as the preprocessing module 20. In one embodiment, the input module 10 has an input area for a user to place samples, such as quality control samples and patient samples. In one embodiment, the input module 10 can also identify the sample type, and the specific implementation can be various. In one embodiment, after the input module 10 receives the sample, the type of the sample is identified according to the area where the user puts the sample into the input module or according to the sample rack where the sample is located. For example, it may be preset which area of the input module 10 has samples as quality control samples and which area has samples as patient samples, so that the input module 10 can identify the type of the samples by identifying which area the samples are located in. For example, a specific type of sample rack may be introduced in advance, the type of sample on the sample rack is identified by the sample rack, for example, two types of sample racks are introduced, each type of sample rack corresponds to one type of sample, for example, one type of sample rack corresponds to a quality control sample, one type of sample rack corresponds to a patient sample, and the input module 10 identifies the type of sample rack by identifying the type of sample rack, for example, by identifying a barcode on the sample rack, so as to obtain the type of sample on the sample rack.
The preprocessing module 20 is used for completing the preprocessing of the sample. In one embodiment, referring to fig. 2, the pre-processing module 20 may include one or more of a centrifuge module 21, a serum detection module 22, a decapping module 23, and a dispensing module 24. The centrifuge modules 21 are used for centrifuging the sample to be centrifuged, and the number of the centrifuge modules 21 may be one or more. The serum test module 22 is used to determine whether the serum amount of the sample is sufficient and/or whether the serum quality of the sample is acceptable, so as to determine whether the centrifuged sample can be used for subsequent determination. The decapping module 23 is used for decapping the centrifuged sample — as will be understood, capping, coating, decapping, and decapping the sample herein, it refers to capping, coating, decapping, and decapping the sample tube containing the sample; typically, the sample is uncapped after centrifugation for subsequent dispensing or pipetting in the dispensing module 24 or in the analysis module. The dispensing module 24 is used to dispense a sample, for example, a sample is divided into a plurality of samples, which are sent to different analysis modules 30 for measurement. The preprocessing module 20 generally has a preprocessing flow: the centrifugal module 21 receives the sample scheduled by the input module 10 and centrifuges the sample; the serum detection module 22 detects serum of the centrifuged sample, and judges whether the serum can be used for subsequent measurement, and if the serum is insufficient in amount or unqualified in quality, the serum cannot be used for subsequent measurement; if the detection is passed, the sample is dispatched to the decapping module 23, the decapping module 23 removes the cap of the sample, if the dispensing module 24 exists, the dispensing module 24 performs the sample splitting on the removed sample, then the sample after the sample splitting is dispatched to the corresponding analysis module 30 for measurement, and if the dispensing module 24 does not exist, the sample is dispatched from the decapping module 23 to the corresponding analysis module 30 for measurement.
The analysis module 30 is used to test the centrifuged and decapped samples. To improve efficiency and test throughput, typically, the pipeline system will have a plurality of analysis modules 30, such as biochemical analysis modules, immunoassay modules, coagulation analysis modules, and the like. These analysis modules 30 may be the same kind of analysis module, i.e., analysis modules for measuring the same item, or different kinds of analysis modules, i.e., analysis modules for measuring different items, which may be configured according to the needs of the user and the department.
The post-processing module 40 is used to complete post-processing of the sample. In one embodiment, referring to fig. 3, the post-treatment module 40 includes one or more of a capping/filming module 41, a refrigerated storage module 42, and a decapping/decapping module 43. The film adding/capping module is used for adding films or caps to the samples; the refrigerated storage module 42 is used for storing samples; the stripping/decapping module is used for stripping or decapping a sample. One typical post-processing flow for post-processing module 40 is: after the sample is aspirated by the analysis module 30, the sample is dispatched to the membrane/capping module 41, and the membrane/capping module 41 performs membrane or capping on the sample after the measurement is completed, and then the sample is dispatched to the cold storage module 42 for storage. If the sample requires retesting, the sample is dispatched from the refrigerated storage module 42, stripped or decapped in a stripping/decapping module 43, and then dispatched to the analysis module 30 for testing.
Referring to fig. 4, as an example of the pipeline system, each module further includes a module buffer, for example, the centrifugal module 21 has a buffer; the track 50 also has a track buffer (a zigzag track in the upper right corner of the figure), and the whole track can be a circular track. It should be noted that there are only one module in many types shown in the figures, but those skilled in the art will understand that there is no limitation on the number, for example, there may be more than one centrifuge module 21, more than one analysis module 30, etc.
In the present invention, when a user puts a quality control sample and a patient sample into an input area of the input module 10 at the same time, the input module 10 recognizes the type of the sample after receiving the sample at its input area. When the input module 10 identifies that the sample type is a quality control sample, the scheduling device 60 schedules the quality control sample to the corresponding analysis module 30 for quality control testing; when the input module 10 identifies the sample type as a patient sample, the pre-processing module 20 performs pre-processing on the patient sample. In some examples, the user may also place the quality control sample into the sample loading area of each analysis module 30 and place the patient sample into the input area of the input module 10, in which case each analysis module 30 begins the quality control test after receiving the quality control sample in its sample loading area; meanwhile, the scheduling device 60 schedules the patient sample from the input module 10 to the pre-processing module 20, and the pre-processing module 20 performs pre-processing on the scheduled patient sample.
It should be noted that, in the above process, each analysis module 30 is in an online state; it can be seen that, in the above process, on one hand, each analysis module 30 is performing its own quality control test, and on the other hand, the pre-processing module 20 of the pipeline system is performing pre-processing on the patient sample. In this process, the controller 70 determines the state of the corresponding analysis module 30 according to the test result of the quality control item of each analysis module 30 and performs calibration; for a pre-processed patient sample, the controller 70 determines the status of the analysis module 30 that needs to be tested for the patient sample, and controls the scheduling device 60 to schedule the patient sample according to the status of the analysis module 30. For example, if the patient sample S is a pre-processed patient sample, when the patient sample S needs to be scheduled to a first analysis module in the pipeline system for testing, the controller 70 determines the status of the first analysis module and then controls the scheduling device 60 to schedule the patient sample S according to the status of the first analysis module.
First, how the controller 70 determines the state of each analysis module 30 according to the test result of the quality control item of each analysis module 30 and performs calibration will be described. The state or quality control state of the analysis module 30 may include an on-control state and a masking state, and in some examples may also include a particular on-control state, as described in more detail below.
Generally, each analysis module 30 in the sample analysis system will have a respective set of control items, and the control samples will be tested for each control item in the set of control items. For any analysis module 30, in an embodiment, the controller 70 determines that the analysis module 30 is in control when determining that the test result of each quality control item in the quality control item set of the analysis module 30 is in control. For any analysis module 30, its quality control item set may be composed of all items supported by itself, for example, the quality control item set of the analysis module 30 may be set to be the set of all items supported by itself by the analysis module 30 in a default or factory condition. In other examples, the laboratory may not need to use all the items of the analysis module 30 for testing in actual use, and in a most probable situation, the laboratory is usually fixed to only use a part of the items supported by the analysis module, so that if the quality control item set of the analysis module is still the set of all the items supported by the laboratory at this time, the laboratory is not only time-consuming and labor-consuming, but also wastes consumables such as quality control items, so that in this case, the provision function may be provided to set the quality control item set of the analysis module, for example, the quality control item set of the analysis module may be set as a set of some items desired by the user — for example, the above example, and the quality control item set of the analysis module may be set as a set of some items in the analysis module that the laboratory is usually fixed to only. In one embodiment, therefore, in response to a user-input command for a set of control items for any one of the analysis modules 30, the controller 70 sets the set of control items for the corresponding analysis module. Therefore, for any analysis module 30, when it is determined that the test result of each quality control item in the quality control item set of the analysis module 30 is in control, the controller 70 marks the state of the analysis module 30 as in-control state. For any analysis module 30, when it is determined that the test result of a quality control item in the quality control item set of the analysis module 30 is out of control or the result of a quality control item is not yet output, the controller 70 marks the state of the analysis module 30 as a shielding state.
In some examples, non-parallel quality control items may also be introduced, and when the quality control item set of the analysis module 30 includes non-parallel quality control items, when it is determined that the test results of all the non-parallel quality control items in the quality control item set of the analysis module 30 are in control and the test results of the remaining quality control items are not all or partially in control, for example, after the non-parallel quality control items are removed, 10 quality control items remain in the quality control item set, wherein 5 quality control items are in control and 5 quality control items have not been in control, the controller 70 marks the state of the analysis module 30 as an in-control state. Typically, for each analysis module 30, their respective quality control items which are easy to lose control and quality control items which are not easy to lose control can be counted; for any analysis module 30, the quality control item which is easy to lose control can be set as the non-parallel quality control item, so that after the test results of the volatile control items in the analysis module 30 are all controlled, if none of the remaining non-controllable items have results, or if part of the remaining non-controllable items have no results, for example, if the volatile control items are removed from the quality control item set, 10 non-controllable items remain, wherein 5 non-controllable items are controlled, and 5 non-controllable items have no results, the analysis module 30 is also marked as the controlled state; of course, if the remaining items that are not likely to be out of control all result and are all in control, the analysis module 30 will be calibrated to be in control state naturally; in addition, it can be understood that, regardless of whether the non-parallel quality control items are included in the quality control item set of the analysis module 30, as long as the quality control items are out of control, the analysis module 30 is calibrated to be in the shielding state by the controller 70.
When the controller 70 determines that the analysis module 30 is in a state where the test result of the quality control item is not in control or the test result of the quality control item is not yet in control, and the test result of the quality control item is in control, the controller 70 releases the shielding of the analysis module 30, and the state of the analysis module 30 is changed from the shielding state to the control state.
It is further described how the controller 70 controls the scheduling means 60 to schedule the patient sample based on the state of the analysis module 30.
In one embodiment, when the controller 70 determines that the status of the analysis module 30 requiring the patient sample to be tested is in control, the controller 70 controls the scheduling device 60 to schedule the patient sample to the analysis module 30 for the patient sample test.
In one embodiment, for a pre-processed patient sample, if the patient sample needs to be tested on each of the plurality of analysis modules 30, when the controller 70 determines that any one of the plurality of analysis modules 30 is in the control state, the patient sample is scheduled to the analysis module 30 in the control state for testing. In some cases, for a pre-processed patient sample, if the patient sample needs to be tested on a plurality of analysis modules 30, respectively, and if the controller 70 determines that at least two of the plurality of analysis modules 30 are under control, the controller 70 may schedule the patient sample to one of the analysis modules 30 in a control state for testing according to the load balancing principle. In addition, after a patient sample is tested on one analysis module 30, for example, after a sample is drawn, when other analysis modules 30 that need to test the patient sample also have an active state, the patient sample is scheduled to be tested in the other analysis modules 30 in the active state. For example, assuming that a pre-processed patient sample S is available, the patient sample S needs to be tested by the first to third analysis modules 30 of the pipeline, and when the controller 70 determines that any one of the analysis modules 30 is in the control state, for example, the second analysis module 30 is in control, the patient sample S is dispatched to the analysis module 30 in the control state, for example, the second analysis module 30, for testing; when the controller 70 determines that both the first and second analysis modules 30 are in control, the controller 70 may dispatch the patient sample S to one of the analysis modules 30 in a control state for testing according to a load balancing principle, for example, if the first analysis module 30 is busy and the second analysis module 30 is relatively idle, the patient sample S is dispatched to the second analysis module 30 for testing; in the example, after the patient sample S is tested by the second analysis module 30, e.g., the draw is completed, if the first analysis module 30 is also in control, the patient sample S is then dispatched to the first analysis module 30 for testing.
In one embodiment, for a pre-processed patient sample, if the patient sample needs to be tested on any one of the plurality of identical analysis modules 30, when the controller 70 determines that any one of the analysis modules 30 is in the control state, the patient sample is dispatched to the analysis module 30 in the control state for testing; in some cases, for a processed patient sample, if at least two of the plurality of identical analysis modules 30 are in control, the controller 70 may schedule the patient sample to one of the analysis modules 30 in control for testing according to a load balancing principle. For example, the pipeline system still has three identical analysis modules, such as the first to third analysis modules 30, and the patient sample S only needs to be tested by one of the three analysis modules 30, and when the controller 70 determines that any one of the three analysis modules 30 is in the control state, such as the second analysis module 30 is in control, the patient sample S is dispatched to the analysis module 30 in the control state, such as the second analysis module 30 described above, to be tested; when the controller 70 determines that both the first and second analysis modules 30 are in control, the controller 70 may dispatch the patient sample S to one of the analysis modules 30 in a control state for testing according to a load balancing principle, such as dispatching the patient sample S to the second analysis module 30 for testing if the first analysis module 30 is busy and the second analysis module 30 is relatively idle.
The above is a scheduling description of how patient samples are scheduled for testing to the analysis module 30 when the analysis module 30 is in the on-control state.
In one embodiment, when the controller determines that the status of the analysis module is in the mask status, the controller 70 controls the scheduling device not to schedule the patient sample to the analysis module for patient sample testing and controls the patient sample to wait; in one embodiment, the controller 70 controls the scheduling device 60 to schedule the patient sample to a predetermined buffer, such as the buffer of the track 50 mentioned in one example above, for waiting. In one embodiment, when the controller 70 determines that the analysis module 30 requiring the patient sample to be tested is changed from the mask state to the on-control state for the patient sample waiting in the buffer, the controller 70 controls the scheduling device 60 to schedule the patient sample from the buffer to the analysis module 30 for testing.
The embodiment of the invention also discloses a testing method (hereinafter referred to as a testing method) of the pipeline system. Referring to fig. 5, the testing method of an embodiment may include steps S100 to S150, which are described in detail below.
Step S100: samples are received at an input area, the samples including quality control samples for quality control and patient samples to be tested.
Step S110: a sample type is identified. In step S110, how to specifically identify whether the sample is a quality control sample or a patient sample can be implemented, the description of identifying the type of the sample by the input module 10 in the foregoing can be referred to, and details are not repeated herein.
Step S120: and when the type of the sample is identified to be the quality control sample, scheduling the quality control sample to a corresponding analysis module for quality control testing.
Step S130: and judging the state of the corresponding analysis module according to the test result of the quality control item of each analysis module and calibrating. For example, for any analysis module, when the test result of each quality control item in the quality control item set of the analysis module is judged to be in control, the state of the analysis module is marked as in-control state; and for any analysis module, when the test result of the quality control item in the quality control item set of the analysis module is judged to be out of control or the result of the quality control item is not obtained, the state of the analysis module is marked as a shielding state. In some examples, non-parallel quality control items may also be introduced, and when a quality control item set of an analysis module includes non-parallel quality control items, when it is determined that test results of all the non-parallel quality control items in the quality control item set of the analysis module are in control, and test results of remaining quality control items are not all output or part of the test results is not output — for example, after the non-parallel quality control items are removed, 10 quality control items remain in the quality control item set, wherein 5 quality control items are in control, and 5 quality control items have not output results, the state of the analysis module is also designated as an in-control state. How to calibrate the states of each module analysis and how to switch between the states, such as changing from the on-control state to the shielding state, changing from the shielding state to the on-control state, etc., in step S130 is described in detail above and is not described herein again.
Step S140: and when the type of the sample is identified as the patient sample, preprocessing the patient sample.
Step S150: for a pre-processed patient sample, determining the state of an analysis module which needs to test the patient sample, and controlling the scheduling of the patient sample according to the state of the analysis module. For example, if the patient sample is in the control state, the patient sample is dispatched to the analysis module for testing; and/or if the patient sample is in the shielding state, the patient sample is not dispatched to the analysis module for patient sample test. In step S150, how to control the scheduling device to schedule the patient sample according to the state of the analysis module is described in detail above, and details are not repeated here.
In the above example, the patient sample and the quality control sample are simultaneously placed in the input area of the pipeline system, and in some cases, the user may also place the quality control sample in the sample loading area of each analysis module and place the patient sample in the input area of the pipeline system (i.e. the input area of the input module).
Step S200: a patient sample to be tested is received at an input area.
Step S210: the patient sample is pre-treated.
Step S220: and receiving a quality control sample in a sample loading area of the analysis module.
Step S230: and the analysis module performs quality control test on the quality control sample in the sample area of the analysis module.
Step S240: and judging the state of the corresponding analysis module according to the test result of the quality control item of each analysis module and calibrating. For example, for any analysis module, when the test result of each quality control item in the quality control item set of the analysis module is judged to be in control, the state of the analysis module is marked as in-control state; for any analysis module, when the test result of a quality control item in the quality control item set of the analysis module is judged to be out of control or the result of the quality control item is not obtained yet, for example, after the non-parallel quality control items are removed, 10 quality control items are remained in the quality control item set, wherein 5 quality control items are under control, and the 5 quality control items are not obtained yet, the state of the analysis module is marked as a shielding state. In some examples, non-parallel quality control items may also be introduced, and when a quality control item set of an analysis module includes the non-parallel quality control items, when it is determined that test results of all the non-parallel quality control items in the quality control item set of the analysis module are in control, and test results of the remaining quality control items are not all output or part of the remaining quality control items are not output, the state of the analysis module is also calibrated to be in control state. How to calibrate the states of each module analysis and how to switch between the states, such as changing from the on-control state to the shielding state, changing from the shielding state to the on-control state, etc., in step S240 is described in detail above and is not described herein again.
Step S250: for a pre-processed patient sample, determining the state of an analysis module which needs to test the patient sample, and controlling the scheduling of the patient sample according to the state of the analysis module. For example, if the patient sample is in the control state, the patient sample is dispatched to the analysis module for testing; and/or if the patient sample is in the shielding state, the patient sample is not dispatched to the analysis module for patient sample test. In step S250, how to control the scheduling device to schedule the patient sample according to the state of the analysis module is described in detail above, and details are not repeated here.
Reference is made herein to various exemplary embodiments. However, those skilled in the art will recognize that changes and modifications may be made to the exemplary embodiments without departing from the scope hereof. For example, the various operational steps, as well as the components used to perform the operational steps, may be implemented in differing ways depending upon the particular application or consideration of any number of cost functions associated with operation of the system (e.g., one or more steps may be deleted, modified or incorporated into other steps).
In the above embodiments, the implementation may be wholly or partially realized by software, hardware, firmware, or any combination thereof. Additionally, as will be appreciated by one skilled in the art, the principles herein may be reflected in a computer program product on a computer readable storage medium, which is pre-loaded with computer readable program code. Any tangible, non-transitory computer-readable storage medium may be used, including magnetic storage devices (hard disks, floppy disks, etc.), optical storage devices (CD-to-ROM, DVD, Blu-Ray discs, etc.), flash memory, and/or the like. These computer program instructions may be loaded onto a general purpose computer, special purpose computer, or other programmable data processing apparatus to produce a machine, such that the instructions which execute on the computer or other programmable data processing apparatus create means for implementing the functions specified. These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including means for implementing the function specified. The computer program instructions may also be loaded onto a computer or other programmable data processing apparatus to cause a series of operational steps to be performed on the computer or other programmable apparatus to produce a computer implemented process such that the instructions which execute on the computer or other programmable apparatus provide steps for implementing the functions specified.
While the principles herein have been illustrated in various embodiments, many modifications of structure, arrangement, proportions, elements, materials, and components particularly adapted to specific environments and operative requirements may be employed without departing from the principles and scope of the present disclosure. The above modifications and other changes or modifications are intended to be included within the scope of this document.
The foregoing detailed description has been described with reference to various embodiments. However, one skilled in the art will recognize that various modifications and changes may be made without departing from the scope of the present disclosure. Accordingly, the disclosure is to be considered in an illustrative and not a restrictive sense, and all such modifications are intended to be included within the scope thereof. Also, advantages, other advantages, and solutions to problems have been described above with regard to various embodiments. However, the benefits, advantages, solutions to problems, and any element(s) that may cause any element(s) to occur or become more pronounced are not to be construed as a critical, required, or essential feature or element of any or all the claims. As used herein, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, system, article, or apparatus. Furthermore, the term "coupled," and any other variation thereof, as used herein, refers to a physical connection, an electrical connection, a magnetic connection, an optical connection, a communicative connection, a functional connection, and/or any other connection.

Claims (17)

1. A pipeline system, comprising:
the input module is used for receiving the sample in an input area and identifying the type of the sample; wherein the samples comprise quality control samples for quality control and patient samples to be tested;
the pretreatment module is used for pretreating a sample; the pretreatment module comprises one or more of a centrifugation module, a serum detection module, a decapping module and a dispensing module; the centrifugal module is used for centrifuging a sample to be centrifuged; the serum detection module is used for detecting whether the serum amount of the sample is enough and/or whether the serum quality of the sample is qualified; the decapping module is used for decapping the centrifuged sample; the separate injection module is used for separating samples;
one or more analysis modules for testing the sample;
the post-processing module is used for performing post-processing on the sample;
the system comprises a track, a scheduling device and a controller, wherein the track is connected with each module; wherein:
when the input module identifies that the sample type is a quality control sample, the scheduling device schedules the quality control sample to a corresponding analysis module for quality control test, when the controller judges that the test result of each quality control item in the quality control item set of the analysis module is controlled, the state of the analysis module is marked as an on-control state, and when the controller judges that the quality control item in the quality control item set of the analysis module is out of control or the result of the quality control item is not present, the state of the analysis module is marked as a shielding state;
when the input module identifies that the sample type is a patient sample, the preprocessing module preprocesses the patient sample, the controller determines the state of an analysis module which needs to test the patient sample for the preprocessed patient sample, if the state is in a control state, the scheduling device schedules the patient sample to the analysis module for testing, and if the state is in a shielding state, the controller controls the scheduling device not to schedule the patient sample to the analysis module for testing.
2. A pipeline system, comprising:
an input module for receiving a patient sample to be tested at an input area thereof;
the pretreatment module is used for pretreating a sample; the pretreatment module comprises one or more of a centrifugation module, a serum detection module, a decapping module and a dispensing module; the centrifugal module is used for centrifuging a sample to be centrifuged; the serum detection module is used for detecting whether the serum amount of the sample is enough and/or whether the serum quality of the sample is qualified; the decapping module is used for decapping the centrifuged sample; the separate injection module is used for separating samples;
one or more analysis modules for testing the sample;
the post-processing module is used for performing post-processing on the sample;
the system comprises a track, a scheduling device and a controller, wherein the track is connected with each module; wherein:
the scheduling device schedules the patient sample to a pretreatment module from an input module, and the pretreatment module pretreats the scheduled patient sample; the analysis module receives a quality control sample in an upper sample area of the analysis module and performs quality control test, the controller marks the state of the analysis module as an on-control state when judging that the test result of each quality control item in the quality control item set of the analysis module is in control, and marks the state of the analysis module as a shielding state when judging that the quality control item in the quality control item set of the analysis module is out of control or the result of the quality control item does not exist;
for a pre-processed patient sample, the controller determines the state of an analysis module which needs to test the patient sample, if the state is in a control state, the scheduling device schedules the patient sample to the analysis module for testing, and if the state is in a shielding state, the controller controls the scheduling device not to schedule the patient sample to the analysis module for testing.
3. A pipeline system, comprising:
the input module is used for receiving the sample in an input area and identifying the type of the sample; wherein the samples comprise quality control samples for quality control and patient samples to be tested;
the pretreatment module is used for pretreating a sample; the pretreatment module comprises one or more of a centrifugation module, a serum detection module, a decapping module and a dispensing module; the centrifugal module is used for centrifuging a sample to be centrifuged; the serum detection module is used for detecting whether the serum amount of the sample is enough and/or whether the serum quality of the sample is qualified; the decapping module is used for decapping the centrifuged sample; the separate injection module is used for separating samples;
one or more analysis modules for testing the sample;
the system comprises a track, a scheduling device and a controller, wherein the track is connected with each module; wherein:
when the input module identifies that the sample type is a quality control sample, the scheduling device schedules the quality control sample to a corresponding analysis module for quality control test, and the controller judges the state of the analysis module according to the test result of the quality control item and calibrates the state;
when the input module identifies that the sample type is a patient sample, the preprocessing module preprocesses the patient sample, for the preprocessed patient sample, the controller determines the state of an analysis module which needs to test the patient sample, and controls the scheduling device to schedule the patient sample according to the state of the analysis module.
4. A pipeline system, comprising:
an input module for receiving a patient sample to be tested at an input area thereof;
the pretreatment module is used for pretreating a sample; the pretreatment module comprises one or more of a centrifugation module, a serum detection module, a decapping module and a dispensing module; the centrifugal module is used for centrifuging a sample to be centrifuged; the serum detection module is used for detecting whether the serum amount of the sample is enough and/or whether the serum quality of the sample is qualified; the decapping module is used for decapping the centrifuged sample; the separate injection module is used for separating samples;
one or more analysis modules for testing the sample;
the system comprises a track, a scheduling device and a controller, wherein the track is connected with each module; wherein:
the scheduling device schedules the patient sample to a pretreatment module from an input module, and the pretreatment module pretreats the scheduled patient sample;
the analysis module receives a quality control sample in an upper sample area of the analysis module, performs quality control test, and the controller judges the state of the analysis module according to the test result of a quality control project and calibrates the state of the analysis module;
for the processed patient sample, the controller determines the state of an analysis module which needs to test the patient sample, and controls the scheduling device to schedule the patient sample according to the state of the analysis module.
5. The pipeline system of claim 3 or 4, wherein the controller determines the state of the analysis module according to the test result of the quality control item and performs calibration, comprising:
when the test results of all the quality control items in the quality control item set of the analysis module are judged to be in control, the controller marks the state of the analysis module as an in-control state; and/or the presence of a gas in the gas,
and when the test result of the quality control item in the quality control item set of the analysis module is judged to be out of control or the result of the quality control item is not obtained, the controller marks the state of the analysis module as a shielding state.
6. The pipeline system of claim 5, wherein the controller determines the state of the analysis module according to the test results of the quality control items and performs calibration, further comprising:
if the quality control item set of the analysis module further comprises preset non-parallel quality control items, when the test results of all the non-parallel quality control items in the quality control item set of the analysis module are judged to be in control and the test results of the rest quality control items are not in control or part of the test results of the rest quality control items are not in control, the controller also marks the state of the analysis module as in control state.
7. The pipeline system of claim 5, wherein when the controller determines that the analysis module is in a state where the test result of the quality control item is not in control or the test result of the quality control item is not yet in control, and the test result of the quality control item is in control, the controller releases the shielding of the analysis module, and the state of the analysis module is changed from the shielding state to the control state.
8. The pipeline system of claim 5, wherein for a pre-processed patient sample, when the controller determines that the status of an analysis module requiring testing of the patient sample is in control, the controller controls the scheduling device to schedule the patient sample to the analysis module for patient sample testing; and/or when the controller determines that the state of the analysis module is the shielding state, the controller controls the scheduling device not to schedule the patient sample to the analysis module for patient sample test and controls the patient sample to wait.
9. The pipeline system of claim 8, wherein for a pre-processed patient sample, if the patient sample needs to be tested on each of the plurality of analysis modules, when the controller determines that any one of the plurality of analysis modules is in the control state, the patient sample is dispatched to the analysis module in the control state for testing.
10. The pipeline system of claim 8, wherein for a pre-processed patient sample, if the patient sample requires testing on any one of a plurality of identical analysis modules, the patient sample is scheduled to be tested on the analysis module in a control state when the controller determines that any one of the analysis modules is in the control state.
11. The pipeline system of claim 9 or 10, wherein when the controller determines that a plurality of the analysis modules are in the on-control state, the patient sample is dispatched to one of the on-control analysis modules for testing according to a load balancing principle.
12. The pipelining system of claim 8, wherein said controller controls patient samples to wait comprising: the controller controls the scheduling device to schedule the patient sample to a preset buffer area for waiting.
13. The pipelining system of claim 12, wherein for a patient sample waiting in said buffer, when the controller determines that an analysis module requiring testing on the patient sample is changed from a mask state to an on-control state, said controller controls the scheduling means to schedule the patient sample from said buffer to the analysis module for testing.
14. The pipeline system of claim 5, wherein the controller sets the set of quality control items for a corresponding analysis module in response to a user input of a quality control item set command for any one of the analysis modules.
15. A method for testing a pipeline system, comprising:
receiving samples at an input area, wherein the samples comprise quality control samples for quality control and patient samples to be tested;
identifying a sample type;
when the type of the sample is identified as a quality control sample, the quality control sample is dispatched to a corresponding analysis module for quality control test, when the test result of each quality control item in the quality control item set of the analysis module is judged to be controlled, the state of the analysis module is marked as a controlled state, and when the quality control item in the quality control item set of the analysis module is judged to be out of control or the result of the quality control item is judged not to be output, the state of the analysis module is marked as a shielding state;
when the type of the sample is identified to be the patient sample, preprocessing the patient sample, and determining the state of an analysis module which needs to test the patient sample for the preprocessed patient sample;
if the patient sample is in the control state, the patient sample is dispatched to the analysis module for testing; and/or if the patient sample is in the shielding state, the patient sample is not dispatched to the analysis module for patient sample test.
16. A method for testing a pipeline system, comprising:
receiving a patient sample to be tested at an input area;
pre-treating a patient sample;
receiving a quality control sample in a sample loading area of an analysis module, performing quality control test, when the test result of each quality control item in a quality control item set of the analysis module is judged to be controlled, calibrating the state of the analysis module to be in a control state, and when the quality control item in the quality control item set of the analysis module is judged to be out of control or the result of the quality control item is not output, calibrating the state of the analysis module to be in a shielding state;
for the patient sample which is processed before, determining the state of an analysis module which needs to test the patient sample;
if the patient sample is under control, the patient sample is dispatched to the analysis module for testing; and/or if the patient sample is in the shielding state, the patient sample is not dispatched to the analysis module for patient sample testing.
17. A computer-readable storage medium, characterized by comprising a program which is executable by a processor to implement the method of claim 15 or 16.
CN201910722319.8A 2019-08-06 2019-08-06 Pipeline system and test method thereof Active CN112345744B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910722319.8A CN112345744B (en) 2019-08-06 2019-08-06 Pipeline system and test method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910722319.8A CN112345744B (en) 2019-08-06 2019-08-06 Pipeline system and test method thereof

Publications (2)

Publication Number Publication Date
CN112345744A true CN112345744A (en) 2021-02-09
CN112345744B CN112345744B (en) 2023-10-20

Family

ID=74367167

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910722319.8A Active CN112345744B (en) 2019-08-06 2019-08-06 Pipeline system and test method thereof

Country Status (1)

Country Link
CN (1) CN112345744B (en)

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050249634A1 (en) * 2004-05-10 2005-11-10 Devlin William J Sr Calibration solution system for use in an automatic clinical analyzer
CN102221625A (en) * 2010-04-14 2011-10-19 深圳迈瑞生物医疗电子股份有限公司 Full-automatic biochemistry analyzer and online sample loading method thereof
CN102735860A (en) * 2011-04-15 2012-10-17 深圳迈瑞生物医疗电子股份有限公司 Method, device and system for treating sample of body fluid examination flow line work station
US8341591B1 (en) * 2006-04-13 2012-12-25 Sprint Communications Company, L.P. Method and software tool for real-time optioning in a software development pipeline
CN103207282A (en) * 2012-01-13 2013-07-17 深圳迈瑞生物医疗电子股份有限公司 Quality control testing method and system for biochemical analysis
CN103460053A (en) * 2011-04-15 2013-12-18 深圳迈瑞生物医疗电子股份有限公司 Body fluid workstation and on-line loading reagent method, system thereof
CN104484582A (en) * 2014-12-08 2015-04-01 深圳华大基因科技服务有限公司 Method and system for automatically analyzing bioinformation items through modular selection
CN105045220A (en) * 2015-05-08 2015-11-11 上海质晟生物科技有限公司 Quality control method based on Z-score quality control chart for multiple variables
CN105929800A (en) * 2016-04-25 2016-09-07 温冬梅 Medical laboratory automation flow line with mobile management system
CN105974894A (en) * 2016-04-25 2016-09-28 温冬梅 Medical laboratory automated assembly line reagent automatic supply method and system
CN106203786A (en) * 2016-06-27 2016-12-07 温冬梅 Medical laboratory's automatic assembly line indoor method of quality control and control system thereof
CN106248977A (en) * 2016-07-06 2016-12-21 温冬梅 The on-line analysis Performance Appraisal System of Health Service Laboratory automatic production line detecting system
CN106568983A (en) * 2016-10-27 2017-04-19 温冬梅 Indoor quality control system for medical laboratory automatic assembly line detection system
CN106596983A (en) * 2015-10-16 2017-04-26 深圳迈瑞生物医疗电子股份有限公司 Sample testing method based on consumable allowance detection and sample analyzer
CN107368700A (en) * 2017-07-21 2017-11-21 上海桑格信息技术有限公司 Based on the microbial diversity interaction analysis system and method for calculating cloud platform
CN107782675A (en) * 2017-09-30 2018-03-09 深圳迈瑞生物医疗电子股份有限公司 A kind of consumable information processing method and biological sample analysis instrument

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050249634A1 (en) * 2004-05-10 2005-11-10 Devlin William J Sr Calibration solution system for use in an automatic clinical analyzer
US8341591B1 (en) * 2006-04-13 2012-12-25 Sprint Communications Company, L.P. Method and software tool for real-time optioning in a software development pipeline
CN102221625A (en) * 2010-04-14 2011-10-19 深圳迈瑞生物医疗电子股份有限公司 Full-automatic biochemistry analyzer and online sample loading method thereof
CN102735860A (en) * 2011-04-15 2012-10-17 深圳迈瑞生物医疗电子股份有限公司 Method, device and system for treating sample of body fluid examination flow line work station
CN103460053A (en) * 2011-04-15 2013-12-18 深圳迈瑞生物医疗电子股份有限公司 Body fluid workstation and on-line loading reagent method, system thereof
CN103207282A (en) * 2012-01-13 2013-07-17 深圳迈瑞生物医疗电子股份有限公司 Quality control testing method and system for biochemical analysis
CN104484582A (en) * 2014-12-08 2015-04-01 深圳华大基因科技服务有限公司 Method and system for automatically analyzing bioinformation items through modular selection
CN105045220A (en) * 2015-05-08 2015-11-11 上海质晟生物科技有限公司 Quality control method based on Z-score quality control chart for multiple variables
CN106596983A (en) * 2015-10-16 2017-04-26 深圳迈瑞生物医疗电子股份有限公司 Sample testing method based on consumable allowance detection and sample analyzer
CN105929800A (en) * 2016-04-25 2016-09-07 温冬梅 Medical laboratory automation flow line with mobile management system
CN105974894A (en) * 2016-04-25 2016-09-28 温冬梅 Medical laboratory automated assembly line reagent automatic supply method and system
CN106203786A (en) * 2016-06-27 2016-12-07 温冬梅 Medical laboratory's automatic assembly line indoor method of quality control and control system thereof
CN106248977A (en) * 2016-07-06 2016-12-21 温冬梅 The on-line analysis Performance Appraisal System of Health Service Laboratory automatic production line detecting system
CN106568983A (en) * 2016-10-27 2017-04-19 温冬梅 Indoor quality control system for medical laboratory automatic assembly line detection system
CN107368700A (en) * 2017-07-21 2017-11-21 上海桑格信息技术有限公司 Based on the microbial diversity interaction analysis system and method for calculating cloud platform
CN107782675A (en) * 2017-09-30 2018-03-09 深圳迈瑞生物医疗电子股份有限公司 A kind of consumable information processing method and biological sample analysis instrument

Also Published As

Publication number Publication date
CN112345744B (en) 2023-10-20

Similar Documents

Publication Publication Date Title
JP6018406B2 (en) Operation method of automatic sample work cell
JP4906431B2 (en) Automatic analyzer
JP7392097B2 (en) Analysis method
JP6307446B2 (en) Centrifuge system, specimen pretreatment system, and control method
CN112798800B (en) Sample analysis system and sample planning method thereof
JP7227948B2 (en) Techniques for checking the condition of analyzers
JPWO2013180017A1 (en) Centrifuge, pretreatment system equipped with centrifuge, and control method of the system
CN112151163A (en) Method, device and system for setting sample priority
CN111398609B (en) Sample rack dispatching method and sample injection processing system
CN112578134A (en) Sample analysis system and control method thereof
CN114556107A (en) Sample analysis system and sample scheduling method thereof
CN112151131A (en) Sample scheduling method, and setting method and system of sample priority
JP2002277477A (en) Automatic analysis system
CN112782411B (en) Sample retest strategy setting method, retest method and sample analysis system
CN112782412A (en) Sample priority setting method, sample priority testing method and sample analysis system
JP2001004639A (en) Automatic analysis system
CN112345744B (en) Pipeline system and test method thereof
JP6476003B2 (en) Automatic analysis system
CN112345776A (en) Sample analysis system, sample analysis device and sample testing method
CN112147347B (en) Sample scheduling method, priority setting method and system
CN112820390A (en) Priority setting method, priority testing method and sample analysis system
CN114636830A (en) Sample analysis apparatus, system and test method thereof
CN112147353B (en) Pipeline system and archiving method of pipeline for measuring samples
CN112345778A (en) Cascade sample analysis system and device and quality control project out-of-control processing method
CN112149938B (en) Pipeline system and sample centrifugation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant